UBS AM’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
270,501
+68,984
+34% +$2.78M ﹤0.01% 1124
2025
Q4
$7.55M Buy
201,517
+17,228
+9% +$578K ﹤0.01% 1258
2025
Q3
$5.45M Sell
184,289
-17,731
-9% -$412K ﹤0.01% 1332
2025
Q2
$4.77M Buy
202,020
+54,740
+37% +$1.14M ﹤0.01% 1732
2025
Q1
$2.66M Buy
147,280
+14,586
+11% +$286K ﹤0.01% 1859
2024
Q4
$2.26M Buy
132,694
+67,634
+104% +$1.17M ﹤0.01% 1975
2024
Q3
$955K Sell
65,060
-17,305
-21% -$217K ﹤0.01% 2418
2024
Q2
$936K Buy
+82,365
New +$899K ﹤0.01% 2408

Other funds holding BTSG

UBS AM's BTSG Position: Q1 2026 in Review

UBS AM increased its BrightSpring Health Services (BTSG) stake by 34% in Q1 2026, buying an estimated $2.78M and bringing the position to 270,501 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

UBS AM first reported a position in BTSG in Q2 2024 and has held it in 8 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • UBS AM held 270,501 shares of BrightSpring Health Services worth $11.5M as of Q1 2026.
  • UBS AM bought 68,984 BrightSpring Health Services shares in Q1 2026, an estimated $2.78M.
  • BrightSpring Health Services made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1124 holding.
  • UBS AM first reported a position in BrightSpring Health Services in Q2 2024 and has held it in 8 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.